Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2024

MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) to Present at 26th Annual Needham Growth Conference

Posted on January 17, 2024 by MissionIR

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, will be participating in this month’s Needham Growth Conference. D-Wave, which is the world’s first commercial supplier of quantum computers, will be represented at the conference … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Reports on 2023 Financial Results, Provides Business Update

Posted on January 17, 2024 by MissionIR

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has released a report on its financial results for the 12-month period ended Sept. 30, 2023; the company also reported on its current business operations. In the report, the company … Continue reading →

Posted in Mullen Automotive Inc. MULN | Leave a comment

Correlate Energy Corp. (CIPI) Bolsters its C-Suite Team and Board of Directors with Three New Appointments; Optimistic About Continued Growth and Success

Posted on January 17, 2024 by MissionIR

Correlate Energy (OTCQB: CIPI), a publicly traded company strategically positioned to capitalize on America’s unstoppable trend toward decentralized energy generation, has announced notable additions to its c-suite team, as well as its board of directors. This follows the successful close … Continue reading →

Posted in Correlate Infrastructure Partners Inc. CIPI | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Set to Expedite Human and Animal Studies on DehydraTECH’s Effectiveness on GLP-1 Drugs Following Positive Results from Pilot Study

Posted on January 17, 2024 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced the final results from its recently completed human Pilot Study #1 that sought to evaluate the effectiveness of its patented DehydraTECH(TM) technology on the oral delivery of … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) ‘Ready to Challenge’ with New Five RS SUV, Reports ‘Road Track’ Article

Posted on January 16, 2024 by MissionIR

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, and its Mullen Five RS were spotlighted in a recent “Road Track” article. The article noted that the sporty new model, which was revealed at CES 2024, is “ready to … Continue reading →

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Extensive GLP-1 Study Program

Posted on January 16, 2024 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today unveiled a comprehensive planned applied research program to thoroughly evaluate DehydraTECH for the improved delivery of GLP-1 drugs, designed to support prospective commercial partnering with global pharmaceutical … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Releases Third-Quarter 2024 Financial Report

Posted on January 16, 2024 by MissionIR

FingerMotion (NASDAQ: FNGR), a mobile services and data company, is reporting on its financial results for the third quarter of fiscal 2024, the period ended Nov. 30, 2023. Numbers to note from the report include quarterly revenue of $6.14 million, … Continue reading →

Posted in FingerMotion Inc. FNGR | Leave a comment

MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Business Update, Milestones

Posted on January 16, 2024 by MissionIR

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, today outlined key accomplishments from 2023 and provided key strategic priorities for 2024. “In 2023, we experienced significant progress in both … Continue reading →

Posted in InMed Pharmaceuticals Inc. INM | Leave a comment

MissionIRNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Releases CEO Shareholder Message

Posted on January 16, 2024 by MissionIR

Renovaro BioSciences (NASDAQ: RENB) (formerly NASDAQ: ENOB), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, has released a message for its shareholders from CEO Mark Dybul. In the message, Dybul provides an update … Continue reading →

Posted in Renovaro BioSciences Inc. RENB | Leave a comment

InvestorBrandNetwork Highlights PaxMedica Inc.’s (NASDAQ: PXMD) Video Release on Transformative ASD Study

Posted on January 16, 2024 by MissionIR

In a significant development for the neurological disorder community, PaxMedica (NASDAQ: PXMD) has released an insightful video detailing the outcomes of its Phase 2 study on Autism Spectrum Disorder (“ASD”), initially published in the Annals of General Psychiatry. This pivotal … Continue reading →

Posted in PaxMedica Inc. PXMD | Leave a comment